Biomarker-based technologies for predicting age of onset are currently being developed for carriers and individuals at 50% risk of autosomal dominant neurodegenerative diseases such as Huntington's disease, frontotemporal dementia and spinocerebellar ataxias.... ...

请注册登录后继续浏览